CL2004001004A1 - Combinacion farmaceutica que comprende irinotecan y revimid para tratar el mieloma multiple. - Google Patents

Combinacion farmaceutica que comprende irinotecan y revimid para tratar el mieloma multiple.

Info

Publication number
CL2004001004A1
CL2004001004A1 CL200401004A CL2004001004A CL2004001004A1 CL 2004001004 A1 CL2004001004 A1 CL 2004001004A1 CL 200401004 A CL200401004 A CL 200401004A CL 2004001004 A CL2004001004 A CL 2004001004A CL 2004001004 A1 CL2004001004 A1 CL 2004001004A1
Authority
CL
Chile
Prior art keywords
revimid
multiple myeloma
pharmaceutical combination
treat multiple
includes irinotecan
Prior art date
Application number
CL200401004A
Other languages
English (en)
Inventor
David Emanuel
Sumant Ramachandra
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CL2004001004A1 publication Critical patent/CL2004001004A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL200401004A 2003-05-19 2004-05-11 Combinacion farmaceutica que comprende irinotecan y revimid para tratar el mieloma multiple. CL2004001004A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47160103P 2003-05-19 2003-05-19

Publications (1)

Publication Number Publication Date
CL2004001004A1 true CL2004001004A1 (es) 2005-03-18

Family

ID=33452451

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200401004A CL2004001004A1 (es) 2003-05-19 2004-05-11 Combinacion farmaceutica que comprende irinotecan y revimid para tratar el mieloma multiple.

Country Status (4)

Country Link
US (1) US20040266809A1 (es)
CL (1) CL2004001004A1 (es)
TW (1) TW200507840A (es)
WO (1) WO2004100953A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002253795B2 (en) 2000-11-30 2007-02-01 The Children's Medical Center Corporation Synthesis of 4-Amino-Thalidomide enantiomers
US7968569B2 (en) 2002-05-17 2011-06-28 Celgene Corporation Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
USRE48890E1 (en) 2002-05-17 2022-01-11 Celgene Corporation Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
US7323479B2 (en) * 2002-05-17 2008-01-29 Celgene Corporation Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
US7393862B2 (en) 2002-05-17 2008-07-01 Celgene Corporation Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
CA2486141A1 (en) 2002-05-17 2003-11-27 Celgene Corporation Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
UA83504C2 (en) 2003-09-04 2008-07-25 Селджин Корпорейшн Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
AP2006003637A0 (en) * 2003-11-06 2006-06-30 Celgene Corp Methods and compositions using thalidomide for thetreatment and management of cancers and other diseases
CL2007002218A1 (es) * 2006-08-03 2008-03-14 Celgene Corp Soc Organizada Ba Uso de 3-(4-amino-1-oxo-1,3-dihidro-isoindol-2-il)-piperidina 2,6-diona para la preparacion de un medicamento util para el tratamiento de linfoma de celula de capa.
WO2012079075A1 (en) 2010-12-10 2012-06-14 Concert Pharmaceuticals, Inc. Deuterated phthalimide derivatives
WO2013130849A1 (en) 2012-02-29 2013-09-06 Concert Pharmaceuticals, Inc. Substituted dioxopiperidinyl phthalimide derivatives
WO2013159026A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Deuterated rigosertib
US9643950B2 (en) 2012-10-22 2017-05-09 Concert Pharmaceuticals, Inc. Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}
WO2014110322A2 (en) 2013-01-11 2014-07-17 Concert Pharmaceuticals, Inc. Substituted dioxopiperidinyl phthalimide derivatives
EP2970364B1 (en) * 2013-03-14 2019-04-24 Andes Biotechnologies Global, Inc. Methods for detecting and treating multiple myeloma
AU2015305449B2 (en) 2014-08-22 2021-05-06 Celgene Corporation Methods of treating multiple myeloma with immunomodulatory compounds in combination with antibodies
JP2018527302A (ja) 2015-06-26 2018-09-20 セルジーン コーポレイション 免疫調節化合物を用いたカポジ肉腫またはｋｓｈｖ誘発性リンパ腫の治療方法、及びバイオマーカーの使用
US10537585B2 (en) 2017-12-18 2020-01-21 Dexcel Pharma Technologies Ltd. Compositions comprising dexamethasone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6147401A (en) * 2000-05-15 2001-11-26 Celgene Corp Compositions and methods for the treatment of cancer
US7968569B2 (en) * 2002-05-17 2011-06-28 Celgene Corporation Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione

Also Published As

Publication number Publication date
US20040266809A1 (en) 2004-12-30
TW200507840A (en) 2005-03-01
WO2004100953A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
CL2004001004A1 (es) Combinacion farmaceutica que comprende irinotecan y revimid para tratar el mieloma multiple.
BRPI0717389A2 (pt) Dispositivos e métodos para avanço de stent
DK1833532T3 (da) Sikkerhedssprøjte
ATE527355T1 (de) Halbweiche immunstimulierende oligonukleotide der c-klasse
BRPI0401856B1 (pt) método para gerenciar área florestal.
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
DK1835907T3 (da) Lægemidler til behandling eller forebyggelse af fibrotiske sygdomme
NL1034745A1 (nl) Vaatstelselverdelingswerkwijzen en -apparatuur.
CL2008000093A1 (es) Compuestos derivados de piridina, inhibidores de p2y12; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de un desorden de agregacion plaquetaria.
ITBO20050535A1 (it) Ugello per dispositivi estinguenti e simili
ITFI20060255A1 (it) Composizione agrochimica, e metodo di trattamento di vegetali conmprendente la somministrazione di tale composizione
ES1061517Y (es) Protector erizo individual y colectivo para arboles y otras plantas.
ES1062095Y (es) Dispositivo para la distribucion de medicamentos.
ITBO20040803A1 (it) Apparecchiatura per la realizzazione di trattamenti antiparassitari.
CL2007002217A1 (es) Composicion farmaceutica que contiene saredutant con un inhibidor selectivo de la recaptacion de serotonina o con un inhibidor de la recaptacion de serotonina/norepinefrina; y uso en la prevencion y el tratamiento de un trastorno depresivo mayor.
ITMO20050089A1 (it) Dispositivo e metodo di protezione.
ES1057085Y (es) Disposicion retenedora para el poliposicionado de jamones y paletillas.
ES1057377Y (es) Estuche para piezas de joyeria y bisuteria.
ES1057389Y (es) Disposicion protectora para tronos procesionales.
ITCL20040002A1 (it) Sistema di protezione del cibo e dell
CL2007003284A1 (es) Composicion farmaceutica que comprende una asociacion de i) ciclobenzaprina, ii) aceclofenaco y opcionalmente iii) excipientes; y su uso para el tratamiento de enfermedades musculares dolorosas.
ITVR20060125A1 (it) Dispositivo e metodo per realizzare catene ornamentali.
ES1056038Y (es) Guantes para manopuntura.
ITBO20060039U1 (it) Apparecchiatura per trattamenti antiparassitari.
DOP2004000807A (es) Barajas que facilitan juegos de naipes